Effect of L-Carnitine Supplementation on Apelin and Apelin Receptor (Apj) Expression in Cardiac Muscle of Obese Diabetic Rats

• Published in: Cell journal (Yakhteh) Vol. 20; no. 3; pp. 427 - 434
• Main Authors: Ranjbar Kohan, Neda, Nazifi, Saeed, Tabandeh, Mohammad Reza, Ansari Lari, Maryam
• Format: Journal Article
• Language: English
• Published: Iran Royan Institute of Iran 01.10.2018; Royan Institute; Royan Institute (ACECR), Tehran
• Subjects: Apelin; Apelin Receptor; Carbohydrates; Cardiac Muscle; Cardiovascular disease; Cardiovascular diseases; Carnitine; Complications; Diabetes; Diabetes mellitus; Diet; Dietary supplements; Drinking water; Gene expression; Glucose; Heart diseases; High carbohydrate diet; High fat diet; Homeostasis; IL-1β; Inflammation; Insulin; Insulin resistance; Interleukins; L-Carnitine; Lipids; Metabolism; Muscles; Obesity; Original; Overexpression; Patients; Polymerase chain reaction; Rats; Receptors; Rodents; Serum levels; Streptozocin; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Iran; L-Carnitine; Cardiac Muscle; Diabetes; Apelin Receptor; Apelin
• DOI: 10.22074/cellj.2018.5408
• ISSN: 2228-5806

L-carnitine (LC) has been shown to protect cardiac metabolism in diabetes patients with cardiovascular diseases (CVDs). Apelin, a newly discovered adipocytokines, is an important regulator of cardiac muscle function; however, the role of the level of expression of Apelin axis in improvement of cardiac function by LC in diabetic patients, is not clear. In the present study, obese insulin-resistant rats were used to determine the effect of LC, when given orally with a high-calorie diet, on Apelin and Apelin receptor (Apj) expression in cardiac muscle. In this experimental study, rats were fed with high-fat/high-carbohydrate diet for five weeks and subsequently were injected with streptozotocin 30 mg/kg for induction of obesity and insulin resistance. After confirming the induction of diabetes (serum glucose above 7.5 mmol/L), the animals received LC 300 mg/kg in drinking water for 28 days. On days 0, 14 and 28 after treatment, cardiac Apelin and Apj gene expression was evaluated by real time polymerase chain reaction (PCR) analysis. Serum levels of insulin, Apelin, glucose, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and the homeostasis model assessment of insulin resistance (HOMA-IR) were also measured using commercial kits. Cardiac Apelin and Apj expression and serum Apelin were increased in obese rats, while LC supplementation decreased the serum levels of Apelin and down-regulated Apelin and Apj expression in cardiac muscle. These changes were associated with reduced insulin resistance markers and serum inflammatory factors and improved lipid profile. We concluded that LC supplementation could attenuate the over-expression of Apelin axis in heart of diabetic rats, a novel mechanism by which LC improves cardiovascular complications in diabetic patients.